The trials expansion highlights the Company's clinical momentum and growing confidence in the device's adoption and Company's ...

Want to see your sale or lease here? Fill out this form to appear in next week’s Pipeline and learn more about what deals we ...

Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosisFeedback from hepatology community supports US market potential from this ...

The investment is set to expand two facilities on US soil and is part of an overarching $50 billion commitment ...

Light Lane Dental Practice in Coventry has announced the introduction of dedicated consultations for patients interested in All-On-4 dental implants, expanding its offering for those seeking long-term ...

“The Bee Sting” by Paul Murray. The plot builds slowly to a breathtaking crescendo. But the real genius is in how it’s told: ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

Management confirmed that the integration of newly acquired CyVantage assets is largely complete, enabling execution of the ...

An IOL-mounted sustained bimatoprost delivery system demonstrated a reduction in IOP in two clinical trials of patients with glaucoma or ocular hypertension, according to a press release from SpyGlass ...

Q3 2025 Earnings Call Transcript November 13, 2025 Nyxoah S.A. misses on earnings expectations. Reported EPS is $-0.74 EPS, ...

The FDA recently approved a pretzel-shaped implant that helps some bladder cancer patients keep their bladder. Dr. Chris ...

Experienced MedTech leader to guide Amber Implants' transition from development into commercialization following FDA clearance of the VCFix® Spinal System Company preparing for U.S. market launch in ...